Newsbenzinga
NanoViricides Announces First Patients Enrolled In Phase 2 Trial Of NV-387 For Mpox In Democratic Republic Of Congo
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…